SOMMADOSSI JEAN-PIERRE (President, CEO, and Chairman) received a stock award from ATEA PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
Common Stock
Shares
+173.47K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+99.52K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−88.60K
Price / share
$3.06
Trade value
$271.12K
% of position
Net shares
+184.38K
Net value
-$271.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2025 | M · Option Exercise | +173.47K | — | — | 148.8% | 116.56K | 290.02K |
| Common Stock Direct | 1/31/2025 | A · Award | +99.52K | — | — | 34.3% | 290.02K | 389.54K |
| Common Stock Direct | 1/31/2025 | F · Tax Withholding | −88.60K | $3.06 | $271.12K | 22.7% | 389.54K | 300.94K |
| Total | +184.38K | -$271.12K | ||||||
Restricted Stock Units
Common Stock
173.47K shares
Shares
−173.47K
Strike price
Held after
173.47K
Exercisable
—
Restricted Stock Units
Common Stock
99.52K shares
Shares
+99.52K
Strike price
Held after
99.52K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
440K shares
Shares
+440K
Strike price
3.06
Held after
440K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock173.47K shares | 1/31/2025 | M · Option Exercise | −173.47K | — | 173.47K | |
| Restricted Stock Units Direct | Common Stock99.52K shares | 1/31/2025 | A · Award | +99.52K | — | 99.52K | |
| Stock Option (Right to Buy) Direct | Common Stock440K shares | 1/31/2025 | A · Award | +440K | 3.06 | — | 440K |
Common Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5.87M | Indirect |
| Total | 5.87M | 5.87M indirect |